Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: Comparison with grapefruit juice

80Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The effect of pomegranate juice (PJ) or grapefruit juice (GFJ) on CYP3A activity was studied in vitro and in healthy human volunteers. In human liver microsomes, the mean 50% inhibitory concentrations (IC50) for PJ and GFJ versus CYP3A (triazolam α-hydroxylation) were 0.61% and 0.55%, (v/v) respectively, without preincubation of inhibitor with microsomes. After preincubation, the IC50 for PJ increased to 0.97% (P

Cite

CITATION STYLE

APA

Farkas, D., Oleson, L. E., Zhao, Y., Harmatz, J. S., Zinny, M. A., Court, M. H., & Greenblatt, D. J. (2007). Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: Comparison with grapefruit juice. Journal of Clinical Pharmacology, 47(3), 286–294. https://doi.org/10.1177/0091270006298359

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free